Itau Unibanco Holding S.A. Clearside Biomedical, Inc. Transaction History

Itau Unibanco Holding S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$0.97 - $1.42 $752 - $1,101	-776 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$1.0 - $6.12 $88 - $538	88 Added 12.79%	776 $1,000
Q3 2018 Nov 13, 2018	SELL	$6.03 - $11.24 $168 - $314	-28 Reduced 3.91%	688 $4,000
Q2 2018 Aug 13, 2018	BUY	$8.91 - $14.54 $2,673 - $4,362	300 Added 72.12%	716 $8,000
Q1 2018 May 14, 2018	BUY	$5.57 - $14.28 $2,317 - $5,940	416 New	416 $4,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $52.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.